Search results for "postmenopause"

showing 10 items of 122 documents

Reduced corneal thickness values in postmenopausal women with dry eye.

2004

To study and compare the corneal thickness values of postmenopausal women with dry eye and postmenopausal women without dry eye.The corneal thickness value of 30 postmenopausal women with dry eye (dry eye group; aged 52 to 55 years) and 32 postmenopausal women without dry eye (normal group; aged 51 to 55 years) was analyzed with the Orbscan Topography System II. Each woman underwent a tear breakup test, the Schirmer test, fluorescein staining of the cornea, and an analysis of the meibomian gland by slit lamp before corneal thickness measurement. The statistical analysis was performed by means of the unpaired Student t test.The mean corneal thickness value was significantly decreased in post…

medicine.medical_specialtyPostmenopausal womengenetic structuresbusiness.industryCorneal TopographyMeibomian GlandsMiddle Agedeye diseasesSurgeryCorneaPostmenopauseOphthalmologyOphthalmologyTearsMedicineHumansBody Weights and MeasuresDry Eye SyndromesFemalesense organsProspective StudiesbusinessCornea
researchProduct

Can Vitamin D deficiency influence muscle perfomance in post-menopausal women? A multicenter retrospective study

2018

Background: The presence of the vitamin D receptor (VDR) has been recently demonstrated in human muscle supporting the theory of a role of vitamin D in the proliferation and differentiation of muscle cells. So far only few studies investigated the association between vitamin D and muscle performance in postmenopausal women. Aim: To define the functional impact of vitamin D deficiency. Design: Multicenter retrospective study. Setting: Five Italian outpatient services of Physical and Rehabilitation Medicine (PRM). Population: Postmenopausal women. Methods: We divided the population in two groups based on the threshold of 30 ng/mL as cut-off to define sufficient and insufficient serum levels o…

medicine.medical_specialtySarcopeniaPopulation030209 endocrinology & metabolismPhysical Therapy Sports Therapy and RehabilitationIsometric exerciseWalkingGastroenterologyCalcitriol receptorvitamin D deficiency03 medical and health sciencesGrip strength0302 clinical medicineHand strengthInternal medicinemedicineVitamin D and neurologyHumans030212 general & internal medicineMuscle StrengthVitamin DeducationAgedRetrospective Studieseducation.field_of_studyVitamin D post menopausal women Knee isometric extension strenght hand grip strenghtHand Strengthbusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaRehabilitationMiddle Agedmedicine.diseaseVitamin D DeficiencyPostmenopausePhysical FitnessPhysical therapyLean body massFemalevitamin D vitamin D deficiency sarcopenia muscle strengthbusiness
researchProduct

Effect of CYP1A1 Gene Polymorphisms on Estrogen Metabolism and Bone Density

2004

UNLABELLED: In this study, we evaluated the effect of polymorphisms of the CYP1A1 gene, linked to hormone-related cancers, on estrogen metabolism and BMD. We found that variants carrying the A allele (CA and AA) for the C4887A polymorphism have a significantly higher degree of estrogen catabolism and lower femoral BMD. INTRODUCTION: Polymorphisms of the CYP1A1 gene, one of the key enzymes that metabolize estrogen, have been linked with hormone-related cancers. We investigated the impact of these polymorphisms on estrogen metabolism and BMD, which is another hormone-dependent health issue. MATERIALS AND METHODS: One hundred seventy postmenopausal women (mean age, 63.5 +/- 0.6 years) particip…

medicine.medical_specialtyTime FactorsGenotypeBone densitymedicine.drug_classEndocrinology Diabetes and MetabolismOsteoporosisRadioimmunoassayBiologyArticleCollagen Type IBone resorptionImmunoenzyme TechniquesAbsorptiometry PhotonBone DensityRisk FactorsInternal medicinehormones and receptorGenotypeCytochrome P-450 CYP1A1medicineHumansosteoporosiOrthopedics and Sports MedicineFemurBone ResorptionAllelesAgedPolymorphism GeneticEstradiolgenetic researchEstrogensMiddle Agedmedicine.diseaseGenotype frequencyPostmenopauseMenopauseEndocrinologyEstrogenepidemiologyFemaleCollagenGene polymorphismMenopausePeptidesPolymorphism Restriction Fragment LengthJournal of Bone and Mineral Research
researchProduct

The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study

2016

Aims Sex hormones could provide a future treatment avenue for dry eye post menopause. However, there are few well-controlled studies. This study investigates the impact of testosterone and oestrogen on dry eye symptoms and signs in postmenopausal women. Methods A randomised double-blind placebo-controlled pilot study was conducted involving 40 women with dry eye (age 63.9±5.1 years, 13.2±6.3 years post menopause). Ten women were assigned to each of four treatment groups: transdermal testosterone, oestradiol, testosterone/oestradiol combination and placebo. Assessment at baseline and after 8 weeks: ocular symptoms, tear osmolarity, tear stability, tear secretion, meibomian gland assessment, …

medicine.medical_specialtyTime Factorsmedicine.drug_classMeibomian glandPhysiologyPilot ProjectsAdministration CutaneousPlacebo03 medical and health sciencesCellular and Molecular Neurosciencechemistry.chemical_compound0302 clinical medicineDehydroepiandrosterone sulfateDouble-Blind MethodInternal medicineHumansMedicineTestosteroneTear secretionRetrospective Studies030219 obstetrics & reproductive medicinebusiness.industryMeibomian GlandsEstrogensTestosterone (patch)Middle AgedAndrogeneye diseasesSensory SystemsPostmenopauseOphthalmologyTreatment Outcomemedicine.anatomical_structureEndocrinologychemistryTearsAndrogens030221 ophthalmology & optometryTearsDry Eye SyndromesFemalesense organsbusinessFollow-Up StudiesHormoneBritish Journal of Ophthalmology
researchProduct

Vulvo-vaginal atrophy: A new treatment modality using thermo-ablative fractional CO2 laser.

2015

a b s t r a c t Objective: To evaluate the efficacy and feasibility of thermo-ablative fractional CO2 laser for the treatment of symptoms related to vulvo-vaginal atrophy (VVA) in post-menopausal women. Methods: From April 2013 to December 2013, post-menopausal patients who complained of one or more VVA-related symptoms and who underwent vaginal treatment with fractional CO2 laser were enrolled in the study. At baseline (T0) and 30 days post-treatment (T1), vaginal status of the women was evaluated using the Vaginal Health Index (VHI), and subjective intensity of VVA symptoms was evaluated using a visual analog scale (VAS). At T1, treatment satisfaction was evaluated using a 5-point Likert …

medicine.medical_specialtyVisual analogue scaleVaginal DiseasesPilot ProjectsGeneral Biochemistry Genetics and Molecular BiologyVulvaAtrophyQuality of lifeLaser treatmentAblative casemedicineHumansAdverse effectbusiness.industryObstetrics and GynecologyMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryMenopausePostmenopauseAdministration IntravaginalDyspareuniaTreatment OutcomeLasers GasQuality of LifeItchingFemaleVaginal atrophyLaser Therapymedicine.symptomAtrophyMenopausebusinessVulvo-vaginal atrophy
researchProduct

The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen

2003

OBJECTIVE To enlighten the early response of endometrium to tamoxifen by assessing the expression of estrogen receptors, progesterone receptors, Ki-67, and the histological response in endometria from normal postmenopausal women treated for 21 days with tamoxifen. DESIGN A total of 40 women, scheduled to undergo vaginal hysterectomy because of uterine prolapse, were randomly assigned to the tamoxifen group (20 mg/day; 20 women) or the control group (20 women). Samples were obtained from the upper and the lower thirds of the uterine cavity. Standard immunohistochemical staining of estrogen and progesterone receptors and of Ki-67 was performed on frozen sections. Staining was assessed using s…

medicine.medical_specialtymedicine.drug_classAdministration OralEstrogen receptorEndometriumEndometriumInternal medicineProgesterone receptormedicineHumansEstrogen receptor betabusiness.industryAntibodies MonoclonalObstetrics and GynecologyMiddle AgedImmunohistochemistryPostmenopauseTamoxifenKi-67 AntigenEndocrinologymedicine.anatomical_structureReceptors EstrogenEstrogenFemaleSimple Endometrial HyperplasiaReceptors ProgesteronebusinessEstrogen receptor alphahormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugMenopause
researchProduct

Women, thrombosis, and cancer: A gender-specific analysis.

2017

Venous thromboembolism (VTE) is a major common complication in cancer patients. Risk-adapted thromboprophylaxis and antithrombotic therapy for patients diagnosed with VTE can reduce the recurrence of VTE events. Thrombotic risk varies according to cancer type, stage, and comorbidities. The current review analyzes most recent data and provides clinical guidance for the management of women with cancer-associated thrombosis.

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentPregnancy Complications CardiovascularLow molecular weight heparin030204 cardiovascular system & hematologyPregnancy Complications Cardiovascular/drug therapy/epidemiology03 medical and health sciences0302 clinical medicinePregnancyRisk FactorsInternal medicineNeoplasmsAntithromboticMedicineHumanscardiovascular diseasesddc:616Venous Thromboembolism/drug therapy/epidemiologybusiness.industryAromatase InhibitorsAnticoagulantCancerAnticoagulantsThrombosisHematologyVenous Thromboembolismmedicine.diseaseequipment and suppliesThrombosisNeoplasms/complications/epidemiologySurgeryPostmenopauseVenous thrombosisAnticoagulants/therapeutic use030220 oncology & carcinogenesisFemaleHormone therapybusinessComplicationPregnancy Complications NeoplasticPregnancy Complications Neoplastic/epidemiologyThrombosis/drug therapy/epidemiologyAromatase Inhibitors/therapeutic useThrombosis research
researchProduct

Diagnosis of Endometrial Carcinoma: Predictive Value of Transvaginal Color Doppler

1995

The objective of this study was to determine whether transvaginal ultrasound plus color Doppler flow improve the ability to diagnose endometrial carcinoma and allow better discrimination between benign and malignant endometrial lesions. One hundred thirty women with abnormal uterine bleeding were evaluated with transvaginal color Doppler before fractional dilatation and curettage (D&C). The endometrial line thickness and endometrial characteristics were evaluated by endosonography. The resistive and pulsatile indices of the uterine arteries and of the endometrium were evaluated with transvaginal color Doppler. Following D&C and tissue diagnosis, women were divided into two groups, 62 with a…

medicine.medical_specialtymedicine.medical_treatmentAdenocarcinomaEndometriumMalignancySensitivity and SpecificityDiagnosis DifferentialPolypsPredictive Value of TestsCarcinomamedicineHumansUltrasonography Doppler ColorGrading (tumors)AgedRetrospective StudiesEpitheliomabusiness.industryUltrasoundObstetrics and GynecologyMiddle Agedmedicine.diseaseCurettageEndometrial NeoplasmsSurgeryPostmenopausemedicine.anatomical_structureCase-Control StudiesEndometrial HyperplasiaAdenocarcinomaFemaleSurgerybusinessJournal of Gynecologic Surgery
researchProduct

Vitamin D levels in Mediterranean breast cancer patients compared with those in healthy women

2018

To evaluate the vitamin D status of postmenopausal women with early estrogen-receptor-positive breast cancer and to compare it with that of healthy postmenopausal women from the same Mediterranean region. STUDY DESIGN AND OUTCOME MEASURES: Data from 691 breast cancer (BC) patients in the B-ABLE cohort were analyzed after recent cancer intervention (recent-BC) or after a minimum of two years since this intervention (long-term-BC). Patients were also stratified by previous chemotherapy exposure (ChT+ and ChT-). Plasma levels of 25-hydroxyvitamin D [25(OH)D] (25(OH)D) were compared with data from 294 healthy women (non-BC) by linear regression to estimate β-coefficients using non-BC participan…

medicine.medical_specialtymedicine.medical_treatmentBreast NeoplasmsGastroenterologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerInternal medicineVitamin D and neurologyHumansChemotherapyMedicineIn patient030212 general & internal medicineVitamin DAgedChemotherapyMediterranean Regionbusiness.industryHealthy populationConfoundingB-ABLE cohort studyObstetrics and GynecologyMiddle AgedVitamin D Deficiencymedicine.diseasePostmenopause030220 oncology & carcinogenesisCohortFemalebusinessBody mass indexMaturitas
researchProduct

Three-dimensional hysterosonography for the study of endometrial tumors: comparison with conventional transvaginal sonography, hysterosalpingography,…

1997

We studied endometrial thickness and homogeneity in 36 patients with postmenopausal bleeding using three-dimensional ultrasound following distention of the uterine cavity with a sterile saline solution (3D-SHSG). Results with 3D-SHSG were compared with findings using transvaginal sonography, transvaginal sonohysterography, transvaginal color Doppler, and hysteroscopy. Sixteen patients (including three on tamoxifen) were undergoing hormone therapy at the time when they were studied. Visualization of the uterine cavity and of endometrial thickness was better with 3D-SHSG than with any of the other ultrasound techniques. The results with 3D-SHSG corresponded to the findings observed with hyste…

medicine.medical_specialtymedicine.medical_treatmentHysteroscopyEndometriumPolypsmedicineHumansHysterosalpingographyHysterosonographyUltrasonographymedicine.diagnostic_testbusiness.industryUltrasoundObstetrics and GynecologyHysterosalpingographyEndometrial NeoplasmsPostmenopausemedicine.anatomical_structureOncologyHysteroscopyEndometrial HyperplasiaFemaleUterine cavityHormone therapyRadiologybusinessTamoxifenmedicine.drugGynecologic oncology
researchProduct